All companies › ASST

ASST · Strive, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells6
Research cases0
Last filing2026-10-05

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-05 — MACEY JONATHAN R · sold 6,700 @ $30.32 2026-10-05 — Sarkhani Arshia · sold 5,634 @ $31.33 2026-10-05 — Beirne Brian Logan · sold 20,077 @ $31.33 2026-10-05 — Lavish James · sold 6,000 @ $30.75 2026-10-05 — Cole Matthew Ryan · sold 58,789 @ $31.33 2026-10-05 — Pham Benjamin · sold 4,209 @ $31.33
2026-10-052026-10-05

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

MACEY JONATHAN R Director
Sarkhani Arshia Chief Marketing Officer, Director
Beirne Brian Logan Chief Legal Officer, Director
Lavish James Director
Cole Matthew Ryan Chief Executive Officer, Director
Pham Benjamin Chief Financial Officer, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ASST is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-05', 'insider_name': 'MACEY JONATHAN R', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 6700.0, 'price': 30.32, 'value': 203144.0, 'is_buy': False}, {'transaction_date': '2026-10-05', 'insider_name': 'Sarkhani Arshia', 'insider_title': 'Chief Marketing Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 5634.0, 'price': 31.3343, 'value': 176537.45, 'is_buy': False}, {'transaction_date': '2026-10-05', 'insider_name': 'Beirne Brian Logan', 'insider_title': 'Chief Legal Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 20077.0, 'price': 31.3343, 'value': 629098.74, 'is_buy': False}, {'transaction_date': '2026-10-05', 'insider_name': 'Lavish James', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 6000.0, 'price': 30.755, 'value': 184530.0, 'is_buy': False}, {'transaction_date': '2026-10-05', 'insider_name': 'Cole Matthew Ryan', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 58789.0, 'price': 31.3343, 'value': 1842112.16, 'is_buy': False}, {'transaction_date': '2026-10-05', 'insider_name': 'Pham Benjamin', 'insider_title': 'Chief Financial Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 4209.0, 'price': 31.3343, 'value': 131886.07, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ASST today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.